A 2023 meta-analysis evaluated the safety and efficacy of benzoyl peroxide (BPO) for reducing Cutibacterium acnes (C. acnes) in the shoulder. A total of 10 surgical studies were included for analysis, all of which utilized 5% BPO alone or in combination with other agents (i.e., clindamycin, chlorhexidine/alcohol). The rate of C. acnes positivity was significantly lower in patients who received 5% BPO compared to patients who did not (odds ratio [OR] 0.16; 95% confidence interval [CI] 0.09 to 0.27; p<0.00001). In patients who received 5% BPO + clindamycin, the rate of positivity for C. acnes was also significantly lower compared to non-BMO (OR 0.20; 95% CI 0.11 to 0.40; p<0.00001). Overall, use of 5% BPO resulted in a significantly lower risk of C. acnes positivity (OR 0.21; 95% CI 0.15 to 0.30; p<0.00001). No difference in C. acnes positivity was found when comparing BPO and BPO + clindamycin (OR 1.00; 95% CI 0.32 to 3.13; p= 1.00). It should be noted that the rate of adverse events was significantly higher with 5% BPO compared to non-BPO (OR 6.04; 95% CI 1.34 to 27.22; p= 0.02). While some publication bias was present in the analysis, there were low levels of heterogeneity. The authors determined that BPO can decrease C. acnes in the shoulder to prevent infection; however, the combination of BPO and clindamycin does not enhance such effects. [1]
A 2022 systematic review and meta-analysis compared the efficacy of chlorhexidine gluconate (CHG) and BPO in reducing C. acnes burden in the shoulder before surgery. A total of ten studies (N= 589 patients) were included, comprised of 6 randomized controlled trials (RCTs), two prospective cohort studies, and two case series. Of eight studies assessing BPO efficacy, 7 used 5% BPO solution, while 1 used a 10% solution; treatment schedules prior to skin culturing varied, as well as drug formulations (i.e., gel versus ointment). Overall, BPO use resulted in a significant reduction in positive cultures versus CHG (risk ratio [RR] 0.46; 95% CI 0.27 to 0.77; p<0.009). C. acnes burden was also significantly reduced in sebaceous glands, dermal layer, and anterior and posterior portal sites after application of 5% BPO. Due to limited data on follow-up, however, conclusions of BPO efficacy in prevention of indolent infections is uncertain. [2]